LSP Advisory BV

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
LSP Advisory BV
CRD #320718
SEC #802-124833
CIK #0001607645
AUM
Employees
Fees
Minimum
Phone31206645500
AddressJohannes Vermeerplein 9
Amsterdam, Netherlands
Source [IAPD] [EDGAR] [Website]
Total AUM ($)
1.00.80.60.40.20.02010201520212027
Type Form D Funds Date Sold AUM
VC EQT Health Economics 3 Cooperatief UA [2025-03-31] 0.6 M 40.3 M
Filed 2025-12-03 (D/A) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
VC LSP Health Economics Fund 2023-03-30 60.2 M
VC LSP Health Economics Fund 2 2023-03-30 216.0 M
VC Life Sciences Partners 7 [2022-03-30] 688.1 M 355.2 M
Offered $1,173,771,000 · Filed 2021-08-19 (D) · Exemption 3(c), 3(c)(7) · Minimum $5,868,855 · Remaining $485,706,440 · Duration More than one year · Revenue Decline to Disclose
VC LSP Dementia Fund [2021-03-30] 50.0 M 124.5 M
Filed 2021-02-11 (D) · Exemption 3(c), 3(c)(7) · Minimum $500,000 · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose
VC Life Sciences Partners 6 CV [2018-03-29] 43.8 M 327.0 M
Offered $43,816,762 · Filed 2018-03-14 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $495,105 · Duration One year or less · Revenue Decline to Disclose
VC Life Sciences Partners V CV [2015-03-30] 54.2 M 202.5 M
Offered $54,171,552 · Filed 2016-06-14 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $111,740 · Duration One year or less · Commission $67,044 · Revenue Not Applicable
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors Role # Filings # Firms 2011 - 2026
Eqt Fund Management Sa RL Promoter 185 4
Peter Veldman Executive Officer 184 4
Sara Huda Executive Officer 91 4
Magnus Sjocrona Executive Officer 74 3
Christiaan Snyders Executive Officer 57 3
Patrik Burnas Executive Officer 36 3
Fouad Azzam Executive Officer 26 2
Martijn Kleijwegt Director, Executive Officer 5 2
Rene Kuijten Director, Executive Officer 4 2
Joachim Rothe Director, Executive Officer 3 2
View All
EDGAR Form CIK 2011 - 2026
SC 13G [0001607645]
Form 13D/13G Filer Form 13D/13G Subject Filed
LSP Advisory BV Cocrystal Pharma Inc [2018-10-18]
LSP Advisory BV Lombard Medical Inc [2014-05-12]
Firm Profile (Form ADV)
LEI724500GWHYKWE7JFBP20
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com